Meeting
2023 ASCO Quality Care Symposium
Associations between patient reported fatigue and remotely monitored activity in patients with prostate cancer receiving androgen deprivation therapy.
Authors
Katherine Barnhill
Cedars-Sinai Medical Center, Los Angeles, CA
Katherine Barnhill, Aubrey Jarman, Carolina Raines, Nora Novikova, Edwin Melencio Posadas, Howard M. Sandler, Stephen J. Freedland, Gillian Gresham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Wearable Devices
Clinical Trial Registration Number
NCT04575402
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 593)
DOI
10.1200/OP.2023.19.11_suppl.593
Abstract #
593
Poster Bd #
N16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio).
First Author: Andrew Warren Hahn
Poster
2022 ASCO Annual Meeting
Feasibility of a novel wrist-worn thermal device for management of vasomotor symptoms in patients with prostate cancer.
First Author: Alicia K. Morgans
Poster
2022 ASCO Genitourinary Cancers Symposium
The effects of a preference-based exercise trial on outcomes in men on androgen deprivation therapy (ADT) for prostate cancer compared to an exercise randomized controlled trial of the same interventions.
First Author: Shabbir M.H. Alibhai
Poster
2021 Genitourinary Cancers Symposium
The effects of bright white light therapy on obese frailty in older men with prostate cancer on hormonal therapy: A pilot randomized control trial.
First Author: Cristiane Decat Bergerot